Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene (Targretin) plus PUVA vs PUVA alone in mycosis fungoides
2004-003701-24Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bexarotene in mycosis fungoides (MF) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Started Aug 2005; status: completed.
02
Drugs
bexarotene
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on 2004-003701-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003701-24.